SEC Filing Details
Document Details
Form
Filing Date
May 19, 2023
Document Date
May 17, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
ORBIMED ADVISORS LLC